13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013740
Total Value
$115.9M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 8,644,579 | $106.4M | 91.82% |
| 2 | Phathom Pharmaceuticals, Inc. | PHAT | 1,167,114 | $9.5M | 8.18% |